Novo Nordisk, Inc.
5 active drug shortages reported by Novo Nordisk, Inc..
Liraglutide Injection
- Category
- Endocrinology/Metabolism
- Reason
- Delay in shipping of the drug
- Updated
- 04/01/2026
Liraglutide Injection
- Category
- Endocrinology/Metabolism
- Reason
- Not specified
- Updated
- 04/01/2026
Liraglutide Injection
- Category
- Endocrinology/Metabolism
- Reason
- Not specified
- Updated
- 04/01/2026
Liraglutide Injection
- Category
- Endocrinology/Metabolism
- Reason
- Not specified
- Updated
- 04/01/2026
Liraglutide Injection
- Category
- Endocrinology/Metabolism
- Reason
- Delay in shipping of the drug
- Updated
- 04/01/2026
This information is not medical advice. Consult your pharmacist. Data is sourced from the FDA Drug Shortage Database and may not reflect real-time inventory at your facility. ShortageWatch is independent and not affiliated with the FDA.